I am ASCPT: Daniel Rosenbloom

Author: [AUTHOR] Published on 7/1/2021 12:00:00 AM

I am ASCPT D Rosenbloom
Daniel Rosebloom, PhD, Associate Principal Scientist, Merck & Co., Brooklyn, New York

What Has Been the Greatest Challenge in Your Career?
As for many of my colleagues, friends, and family, 2020 has been difficult—both personally and professionally. It is hard to think of a more challenging time in my career so far, and the pandemic has added much stress. This year, I’ve taken on new responsibilities, including a lead role in developing pharmacokinetic modeling materials for a drug filing, the first time I’ve been involved in such an effort. I was grateful for guidance from talented and experienced teammates to help me through, and I’m proud of what we’ve accomplished.

How Do You Keep Focused and Motivated?
Getting outside and having some aspects of a normal social life (at a distance!) certainly helps. Yoga and meditation also help me take a step back and regain some balance—although I wish I kept a more regular schedule for this practice. At work, I have a supportive team, and we can rely on each other through challenging and time-senstive tasks. I find that envisioning precisely how my work will be used by my colleagues is a great source of motivation and focus for me. To bridge the gap between immediate focus and “big picture” goals, I have also found conversations with patient advocate and community leaders to be helpful—they are skilled at presenting a focused, personal need that breaks through abstract notions of “the patient.” In the HIV field in particular, I have found the magazine Positively Aware a useful resource to learn from the communities that we serve.

While I am hunkered down writing or coding, having instrumental music on loop helps too (I cannot concentrate at all if there are any words!). Recent playlist selections include piano renditions of Elton John, Piano Guys albums, and pieces by trumpet artist and name-doppelgänger, Dan Rosenboom.

What Is Your Favorite Society Memory?
My introduction to the Society was at ASCPT 2015, when I was a postdoc. I was working on several topics in virology and oncology but nothing directly “pharmafacing.” As the conference was my first introduction to clinical pharmacology, many of the presentations went over my head. But I came away with a vivid impression of how the academic work in which I had been involved for the past 7 years could translate to the world of drug development in a concrete way. I also met one of the colleagues who introduced me to my current department at Merck.

More recently, I had the pleasure of working with the editors of CPT: Pharmacometrics & Systems Pharmacology (PSP) as an editor-in-training for 2020. It was a great learning opportunity for me, to see how PSP and other Society journals function and to promote recent research—make sure to follow @ASCPTjournals on Twitter!

What Was Your Childhood Dream Job?
As a child, I wanted to be both a mathematician and a department store manager. I had no idea what a mathematician truly did, but I was good with numbers and found learning math exciting, so it felt like a natural choice. And running a department store seemed like the perfect way to learn a little bit about everything! I like to believe that my 8-year-old self would think that my current job as an industry pharmacometrician—an applied mathematician developing a variety of new products—is actually pretty cool. ASCPT now just needs a Thanksgiving Day Parade.

When You Aren’t Working, How Do You Spend Your Free Time?
Before 2020: Wandering through cities around the world and finding good restaurants.

In 2020: Wandering through my neighborhood and finding good take-out!

Dr. Rosenbloom has been a member of ASCPT since 2019.

Sort by:
Photo Gallery
Recent News
  • FDA Approves KERENDIA (Finerenone) to Reduce the Risk of Sustained EGFR Decline, End Stage Kidney Disease, Cardiovascular Death, Non-Fatal Myocardial Infarction, and Hospitalization for Heart Failure in Adult Patients with CKD Associated with T2D
    July 23, 2021
  • FDA and Duke-Margolis Announce a Public Workshop Entitled “Pharmacodynamic Biomarkers for Biosimilar Development and Approval” for September 20 – 21, 2021
    July 23, 2021
  • CTS Students and Trainees Step Into the Spotlight
    July 20, 2021
Contact Us